Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_281ddfab28e479043e907cb567a683a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe9efcec7d9ed77f844ba87d886fb92c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b0f98295cffaef56cd6730d355196fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13b96e60796ac41a46433b381989f2de http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1f28245f42e246cff1793d4e0e4e912 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4edc3844c7bd735a3653173e9d87eed |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
filingDate |
2012-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d79dea0c483ab4f6c63ba8034b7f978a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3de99e5ac114f5c316a32cd0fd948daa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e4c680dee806d776881bfedad6776e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5640a14c9d57aef7274d5b3ffb9be8af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dd5481db6d9beabc8ed4a9f245d4791 |
publicationDate |
2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9233143-B2 |
titleOfInvention |
Medicinal agent for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor GC-A and GC-B agonists |
abstract |
Provided are a medicinal agent which is highly safe for use as the treatment of a malignant tumor and is capable of efficiently treating a malignant tumor, that is, a medicinal agent for treating a malignant tumor or for suppressing or preventing the exacerbation thereof, comprising at least one kind of natriuretic peptide receptor GC-A agonist and at least one kind of natriuretic peptide receptor GC-B agonist to be administered in combination; a therapeutic method comprising administering the agent; etc. |
priorityDate |
2011-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |